… ProQR Announces R&D Day and Provides Update on Innovation Portfolio First … NY LEIDEN, Netherlands, Nov. 30, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … to the future of medicine,” said Daniel de Boer, CEO of ProQR. “Our innovation platform has been very efficient and …
… ProQR Prices $50 Million Underwritten Public Offering of … and CAMBRIDGE, Mass., Oct. 15, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a biopharmaceutical … of $5.50 per share. All of the shares are being offered by ProQR. In addition, ProQR has granted the underwriters a …
… ProQR Appoints Naveed Shams, MD, PhD as Chief Scientific … medicine platform from David Rodman, MD, who is departing ProQR. Dr. Shams brings to ProQR deep ophthalmology, … provide strategic direction, oversight, and execution for ProQR’s research and early development efforts. This entails …
… ProQR to Present at Upcoming JMP Securities Life Sciences … will be accessible from the “Investors & Media” section of ProQR’s website ( www.proqr.com ) under “ Eve n ts ”. The archived webcast will …
… ProQR to Present at Upcoming Scientific Meeting and Investor … at 9:30am EST, Daniel de Boer, Chief Executive Officer of ProQR, will present at the LEERINK 7 th Annual Global … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and …
… ProQR Announces Financial Results for the Third Quarter of … LCA10,” said Daniel A. de Boer, chief executive officer of ProQR. “These results build confidence in QR-110 and the … for QR-110 in patients with LCA10 and preclinical data for ProQR’s Axiomer ® RNA-editing technology. Abstract titles: …
… ProQR to Present at the Chardan Inaugural Gene Therapy … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …
